Graz, Austria

Martin Ellmerer


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martin Ellmerer: Innovator in Glucose-Regulating Medication Delivery

Introduction

Martin Ellmerer is a notable inventor based in Graz, Austria. He has made significant contributions to the field of medical technology, particularly in the delivery of glucose-regulating medications. His innovative approach aims to improve the management of diabetes through advanced devices.

Latest Patents

Ellmerer holds a patent for a device and method for the delivery of a physiologically active substance depending on a measured physiological parameter. This device is specifically designed for the delivery of glucose-regulating medication, such as insulin, based on the measured tissue glucose concentration. The invention includes a sensor for measuring glucose levels in tissue fluid, a unit for removing fluid from subcutaneous tissue, and a container for the medications. The device simulates the function of the natural pancreas and is constructed to be small and compact. The integration of the glucose sensor with the delivery unit allows for precise regulation of medication delivery based on real-time glucose measurements.

Career Highlights

Ellmerer is affiliated with the Medical University of Graz, where he continues to work on innovative solutions in medical technology. His research focuses on enhancing the effectiveness of diabetes management through advanced delivery systems.

Collaborations

He collaborates with esteemed colleagues such as Werner Regittnig and Thomas Pieber, contributing to a dynamic research environment that fosters innovation in medical devices.

Conclusion

Martin Ellmerer is a pioneering inventor whose work in glucose-regulating medication delivery has the potential to transform diabetes management. His contributions reflect a commitment to improving patient care through innovative technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…